Don't miss out! Learn about Scilligence's RegMol during Amjad Nasir's presentation on Tuesday, February 27th.
Talk Abstract:
The pharmaceutical industry is transitioning from traditional Small Molecule therapeutics to Biologics-based therapeutics (antibodies, proteins, oligonucleotides and peptides, etc.).
At Scilligence, our goal is to provide the scientist with a unified informatics platform that embraces multi-modal entities - RegMol is a Registration and Assay Management system that enables scientists to do just that.
Users can register antibody-drug conjugates, peptides, oligonucleotides, and LNPs, to name a few. RegMol also automatically tracks the relationships between all of these registered entities - this enables the User to have a comprehensive overview of how Entities are linked to each other.
RegMol's architecture enables Users to configure registration forms to suit their workflows and thereby evolve to meet their scientific needs in a single system without the need for any custom code.
#entityregistration #scienceandtechnology #freeevent
https://lnkd.in/esJGBbrc